Imposed ​ ​Leadership

As processes involved in R & D evolve, they become more complex and acquire density; both, the pharma and the research site, face situations where multiple constraints are interrelated. This constant exposure to exo-endogenous factors, inherent to continuous changes, requires periodic testing and review of results.